MediWound (MDWD) Non-Current Deffered Revenue (2013 - 2022)
MediWound (MDWD) recorded quarterly Non-Current Deffered Revenue of $31000.0 in Q3 2022, down 49.18% quarter-over-quarter from $61000.0 in Q2 2022, and down 91.19% on a YoY basis from $352000.0 in Q3 2021.
MediWound (MDWD) Non-Current Deffered Revenue (2013 - 2022) Analysis & Trends
MediWound's Non-Current Deffered Revenue history runs 8 years deep, the most recent figure standing at $31000.0 for Q3 2022.
- In Q3 2022, Non-Current Deffered Revenue fell 91.19% year-over-year to $31000.0; the TTM figure through Sep 2022 stood at $31000.0 (down 91.19% YoY), while the FY2021 annual figure was $119000.0, down 90.36% from the prior year.
- Non-Current Deffered Revenue was $31000.0 for Q3 2022 at MediWound, down from $61000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.3 million in Q1 2018 to a low of $31000.0 in Q3 2022.
- Historically, Non-Current Deffered Revenue has averaged $835421.1 across 5 years, with a median of $1.1 million in 2019.
- The sharpest annual moves came in 2018 and 2022: Non-Current Deffered Revenue soared 35.58% in 2018, then plunged 91.19% in 2022.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $1.2 million in 2018, then decreased by 1.99% to $1.1 million in 2019, then climbed by 8.72% to $1.2 million in 2020, then plunged by 90.36% to $119000.0 in 2021, then slumped by 73.95% to $31000.0 in 2022.
- The last three Non-Current Deffered Revenue figures came in at $31000.0 (Q3 2022), $61000.0 (Q2 2022), and $91000.0 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 61,000.00 |
| Mar 31, 2022 | 91,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 352,000.00 |
| Jun 30, 2021 | 405,000.00 |
| Mar 31, 2021 | 693,000.00 |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 1.28 Mn |
| Jun 30, 2020 | 1.17 Mn |
| Mar 31, 2020 | 1.02 Mn |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Jun 30, 2019 | 1.14 Mn |
| Mar 31, 2019 | 1.15 Mn |
| Dec 31, 2018 | 1.16 Mn |
| Sep 30, 2018 | 1.17 Mn |
| Jun 30, 2018 | 1.18 Mn |
| Mar 31, 2018 | 1.35 Mn |
| Dec 31, 2017 | 988,000.00 |